Luis E. Raez/X
Jan 28, 2024, 18:17
Luis E. Raez: There is no really benefit adding anti-VEGF to TKIs for EGFR tumors
Luis E. Raez, Medical Director of Memorial Cancer Institute, shared a post on X/Twitter:
“Our metanalysis in Frontiers confirming there is no really benefit adding anti-VEGF to TKIs for EGFR tumors. Congrats to the Peruvian team from Aliada for putting this together!”
Source: Luis E. Raez/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 14, 2024, 13:49
Nov 14, 2024, 13:44
Nov 14, 2024, 13:37
Nov 14, 2024, 13:32
Nov 14, 2024, 13:29
Nov 14, 2024, 13:02
Nov 14, 2024, 12:44